Paul M, Saibil SD, Han S, Israni-Winger K, Lien SC, Laister RC, Sayad A, Penny S, Amaria RN, Haydu LE, et al
Gene expression on BDNF and SK-3 was quantified using real-time PCR, revealing that VPA reduced the expression BDNF, which plays a crucial role in synaptic plasticity and neuronal survival, and increased GSK-3, which is involved in neurodevelopment and neuroinflammation whereas crocin dose-dependently normalized both markers ( Weight of evidence: Overall evidence is LowModerate in VPA models
Some uremic toxins, such as p-CS and IS, were also lowered by the supplements
Oligomeric and fibrillar species of amyloid- peptides differentially affect neuronal viability
PubMed 37364590 Regulatory status: Cagrilintide is not an approved human medicinal product in any regulatory zone (FDA, EMA, KL) as of the publication date